Search

Gary B. Nickol

Supervisory Patent Examiner (ID: 17728, Phone: (571)272-0835 , Office: P/1645 )

Most Active Art Unit
1642
Art Unit(s)
OPT, 1643, 1642, 1646, 1645
Total Applications
533
Issued Applications
167
Pending Applications
180
Abandoned Applications
184

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6613725 [patent_doc_number] => 20020015970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators' [patent_app_type] => new [patent_app_number] => 09/738877 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27664 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20020015970.pdf [firstpage_image] =>[orig_patent_app_number] => 09738877 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/738877
Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators Dec 14, 2000 Abandoned
60/367360 Novel death domain proteins Nov 16, 2000 Pending
Array ( [id] => 778986 [patent_doc_number] => 06994852 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-07 [patent_title] => 'Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5' [patent_app_type] => utility [patent_app_number] => 10/129946 [patent_app_country] => US [patent_app_date] => 2000-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 6654 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/994/06994852.pdf [firstpage_image] =>[orig_patent_app_number] => 10129946 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/129946
Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 Nov 9, 2000 Issued
Array ( [id] => 1559262 [patent_doc_number] => 06436629 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Modulating angiogenesis' [patent_app_type] => B1 [patent_app_number] => 09/697854 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6376 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436629.pdf [firstpage_image] =>[orig_patent_app_number] => 09697854 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/697854
Modulating angiogenesis Oct 26, 2000 Issued
Array ( [id] => 1305726 [patent_doc_number] => 06617102 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Tankyrase H, compositions involved in the cell cycle and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/696668 [patent_app_country] => US [patent_app_date] => 2000-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 30540 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/617/06617102.pdf [firstpage_image] =>[orig_patent_app_number] => 09696668 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/696668
Tankyrase H, compositions involved in the cell cycle and methods of use Oct 24, 2000 Issued
09/691492 Method for the genetic analysis of proliferating cells Oct 17, 2000 Abandoned
Array ( [id] => 1344321 [patent_doc_number] => 06579525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Pharmaceutical compositions comprising erythropoietin for treatment of cancer' [patent_app_type] => B1 [patent_app_number] => 09/647761 [patent_app_country] => US [patent_app_date] => 2000-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8583 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579525.pdf [firstpage_image] =>[orig_patent_app_number] => 09647761 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/647761
Pharmaceutical compositions comprising erythropoietin for treatment of cancer Oct 4, 2000 Issued
09/684458 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization Oct 4, 2000 Abandoned
Array ( [id] => 1009260 [patent_doc_number] => 06900022 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Prostate cancer-specific marker' [patent_app_type] => utility [patent_app_number] => 09/680121 [patent_app_country] => US [patent_app_date] => 2000-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 22018 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900022.pdf [firstpage_image] =>[orig_patent_app_number] => 09680121 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/680121
Prostate cancer-specific marker Oct 3, 2000 Issued
09/675904 Methods for diagnosis and therapy of hematological and virus-associated malignancies Sep 27, 2000 Abandoned
09/670128 Methods for cancer prognosis and screening antiproliferative agents Sep 25, 2000 Abandoned
Array ( [id] => 1334829 [patent_doc_number] => 06596851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Inducible phosphofructokinase and the Warburg effect' [patent_app_type] => B1 [patent_app_number] => 09/670216 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8548 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596851.pdf [firstpage_image] =>[orig_patent_app_number] => 09670216 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/670216
Inducible phosphofructokinase and the Warburg effect Sep 24, 2000 Issued
Array ( [id] => 642205 [patent_doc_number] => 07122630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-17 [patent_title] => 'SYK-UBP polypeptides and methods of making and isolating same' [patent_app_type] => utility [patent_app_number] => 10/088960 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 25159 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122630.pdf [firstpage_image] =>[orig_patent_app_number] => 10088960 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/088960
SYK-UBP polypeptides and methods of making and isolating same Sep 24, 2000 Issued
Array ( [id] => 1392113 [patent_doc_number] => 06537554 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis' [patent_app_type] => B1 [patent_app_number] => 09/658644 [patent_app_country] => US [patent_app_date] => 2000-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12608 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537554.pdf [firstpage_image] =>[orig_patent_app_number] => 09658644 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/658644
Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis Sep 10, 2000 Issued
Array ( [id] => 1324365 [patent_doc_number] => 06599495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Nucleotide and protein sequence of mammastatin and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/643476 [patent_app_country] => US [patent_app_date] => 2000-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17169 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599495.pdf [firstpage_image] =>[orig_patent_app_number] => 09643476 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/643476
Nucleotide and protein sequence of mammastatin and methods of use Aug 21, 2000 Issued
09/638280 Methods for diagnosis and therapy of hematological and virus-associated malignancies Aug 13, 2000 Abandoned
Array ( [id] => 1511917 [patent_doc_number] => 06472142 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Methods and means for inducing apoptosis by interfering with Bip-like proteins' [patent_app_type] => B1 [patent_app_number] => 09/581001 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12120 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472142.pdf [firstpage_image] =>[orig_patent_app_number] => 09581001 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/581001
Methods and means for inducing apoptosis by interfering with Bip-like proteins Jul 23, 2000 Issued
Array ( [id] => 663642 [patent_doc_number] => 07101975 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins' [patent_app_type] => utility [patent_app_number] => 09/615624 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12952 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101975.pdf [firstpage_image] =>[orig_patent_app_number] => 09615624 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/615624
Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins Jul 12, 2000 Issued
Array ( [id] => 732174 [patent_doc_number] => 07037667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Tumor antigen useful in diagnosis and therapy of prostate and colon cancer' [patent_app_type] => utility [patent_app_number] => 09/615285 [patent_app_country] => US [patent_app_date] => 2000-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 36 [patent_no_of_words] => 43055 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037667.pdf [firstpage_image] =>[orig_patent_app_number] => 09615285 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/615285
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer Jul 11, 2000 Issued
Array ( [id] => 1034633 [patent_doc_number] => 06875844 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-05 [patent_title] => 'Peptide compounds derived from a shifted ORF of the iCE gene' [patent_app_type] => utility [patent_app_number] => 10/019219 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 9923 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875844.pdf [firstpage_image] =>[orig_patent_app_number] => 10019219 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/019219
Peptide compounds derived from a shifted ORF of the iCE gene Jun 26, 2000 Issued
Menu